| Dr Katharine Anna Kenyon Hodinka, MD | |
|
7920 Acc Blvd Ste 100, Raleigh, NC 27617-8744 | |
| (919) 596-9600 | |
| (919) 596-9696 |
| Full Name | Dr Katharine Anna Kenyon Hodinka |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 8 Years |
| Location | 7920 Acc Blvd Ste 100, Raleigh, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174971626 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 03053 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Carolina Dermatology Associates Pllc | 8921162942 | 3 |
News Archive
Many parents are putting their precious cargo at risk while driving, according to survey results that will be presented May 5 and 6 at the Pediatric Academic Societies (PAS) annual meeting in Washington, DC.
A study published in the current issue of the Journal of the National Cancer Institute (JNCI) concludes that genotyping of specific high-risk types of the human papillomavirus (HPV), the cause of virtually all cases of cervical cancer, can benefit clinical practice by enabling more focused attention on women who are at highest risk, announced Digene Corporation.
Following the conclusion of a two-day meeting at the National Institutes of Health (NIH) this week - meant "to gather feedback from flu researchers, others in the science community, and the public on its draft framework for funding H5N1 gain-of-function studies and to continue an international dialogue on issues related to benefits and risks of the research" - "experts anticipated that a voluntary moratorium on work with lab-modified strains that have increased transmissibility might end soon," CIDRAP News reports.
Treatment with a protein fused to an antibody in tumor-bearing mice led to coagulation of the blood within the tumor blood vessels, tumor tissue death, and tumor growth delay, according to a new study in the May 18 issue of the Journal of the National Cancer Institute.
Although SGLT-2 inhibitors are central to the treatment of diabetes, their exact mode of action was hitherto unknown.
› Verified 6 days ago
| Entity Name | North Carolina Dermatology Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467608984 PECOS PAC ID: 8921162942 Enrollment ID: O20090205000326 |
News Archive
Many parents are putting their precious cargo at risk while driving, according to survey results that will be presented May 5 and 6 at the Pediatric Academic Societies (PAS) annual meeting in Washington, DC.
A study published in the current issue of the Journal of the National Cancer Institute (JNCI) concludes that genotyping of specific high-risk types of the human papillomavirus (HPV), the cause of virtually all cases of cervical cancer, can benefit clinical practice by enabling more focused attention on women who are at highest risk, announced Digene Corporation.
Following the conclusion of a two-day meeting at the National Institutes of Health (NIH) this week - meant "to gather feedback from flu researchers, others in the science community, and the public on its draft framework for funding H5N1 gain-of-function studies and to continue an international dialogue on issues related to benefits and risks of the research" - "experts anticipated that a voluntary moratorium on work with lab-modified strains that have increased transmissibility might end soon," CIDRAP News reports.
Treatment with a protein fused to an antibody in tumor-bearing mice led to coagulation of the blood within the tumor blood vessels, tumor tissue death, and tumor growth delay, according to a new study in the May 18 issue of the Journal of the National Cancer Institute.
Although SGLT-2 inhibitors are central to the treatment of diabetes, their exact mode of action was hitherto unknown.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katharine Anna Kenyon Hodinka, MD 7920 Acc Blvd Ste 100, Raleigh, NC 27617-8744 Ph: (919) 596-9600 | Dr Katharine Anna Kenyon Hodinka, MD 7920 Acc Blvd Ste 100, Raleigh, NC 27617-8744 Ph: (919) 596-9600 |
News Archive
Many parents are putting their precious cargo at risk while driving, according to survey results that will be presented May 5 and 6 at the Pediatric Academic Societies (PAS) annual meeting in Washington, DC.
A study published in the current issue of the Journal of the National Cancer Institute (JNCI) concludes that genotyping of specific high-risk types of the human papillomavirus (HPV), the cause of virtually all cases of cervical cancer, can benefit clinical practice by enabling more focused attention on women who are at highest risk, announced Digene Corporation.
Following the conclusion of a two-day meeting at the National Institutes of Health (NIH) this week - meant "to gather feedback from flu researchers, others in the science community, and the public on its draft framework for funding H5N1 gain-of-function studies and to continue an international dialogue on issues related to benefits and risks of the research" - "experts anticipated that a voluntary moratorium on work with lab-modified strains that have increased transmissibility might end soon," CIDRAP News reports.
Treatment with a protein fused to an antibody in tumor-bearing mice led to coagulation of the blood within the tumor blood vessels, tumor tissue death, and tumor growth delay, according to a new study in the May 18 issue of the Journal of the National Cancer Institute.
Although SGLT-2 inhibitors are central to the treatment of diabetes, their exact mode of action was hitherto unknown.
› Verified 6 days ago
Gregory J Wilmoth, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4201 Lake Boone Trl, Suite 200, Raleigh, NC 27607 Phone: 919-782-2152 Fax: 919-782-7929 | |
Kara V Signorelli, MD Dermatology Medicare: Medicare Enrolled Practice Location: 800 Springfield Commons Dr Ste 115, Raleigh, NC 27609 Phone: 919-876-3656 Fax: 919-876-2351 | |
Dr. Carrie Deener Alspaugh, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3225 Blue Ridge Rd, Suite 101, Raleigh, NC 27612 Phone: 919-781-1050 Fax: 919-510-5090 | |
Audrey F Echt, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 10931 Raven Ridge Rd, Ste 101, Raleigh, NC 27614 Phone: 919-870-6600 Fax: 919-870-1610 | |
Dr. Lisa Abernethy Christman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 Springfield Commons Dr Ste 115, Raleigh, NC 27609 Phone: 919-876-3656 Fax: 919-876-2351 | |
Dr. Kendall S Hash, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3225 Blue Ridge Rd, Suite 101, Raleigh, NC 27612 Phone: 919-781-1050 Fax: 919-510-5090 |